FMP

FMP

Enter

BCDA - BioCardia, Inc.

photo-url-https://financialmodelingprep.com/image-stock/BCDA.png

BioCardia, Inc.

BCDA

NASDAQ

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.

2.65 USD

-0.04 (-1.51%)

About

ceo

Dr. Peter A. Altman Ph.D.

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscl...

CIK

0000925741

ISIN

US09060U5074

CUSIP

09060U507

Address

320 Soquel Way

Phone

650 226 0120

Country

US

Employee

16

IPO Date

Nov 13, 1996

BCDA Financial Summary

CIK

0000925741

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

09060U507

ISIN

US09060U5074

Country

US

Price

2.65

Beta

1.26

Volume Avg.

845.41k

Market Cap

9.28M

Shares

-

52-Week

1.96-23.25

DCF

-0.27

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.5

P/B

-

Website

https://www.biocardia.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest BCDA News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep